Simpson M L, Khan M Y, Siddiqui Y, Gruninger R P, Wigren D I
Antimicrob Agents Chemother. 1981 May;19(5):798-800. doi: 10.1128/AAC.19.5.798.
Ninety-seven patients with 118 sites infected with Neisseria gonorrhoeae were treated with a single dose of either procaine penicillin G (4.8 x 10(6) U) or cefotoxime (1.0 g) intramuscularly. Only the penicillin group took 1 g of probenecid orally. The numbers of infected sites in each treatment group were as follows: penicillin-urethra, 37; rectum, 9; cervix, 8; and pharynx, 4; cefotaxime-urethra, 42; rectum, 9; cervix, 5; and pharynx, 4. The cure rates in each treatment group were 100%. No adverse reactions were noted in either group. beta-Lactamase-positive N. gonorrhoeae strains were not found. Ninety-five percent of clinical isolates were inhibited by less than or equal to 0.007 micrograms of cefotaxime and less than or equal to 0.25 micrograms of penicillin per ml. In this study cefotaxime was as effective as procaine penicillin in the treatment of uncomplicated gonorrhea.
对97例共118个感染淋病奈瑟菌部位的患者,分别单次肌内注射普鲁卡因青霉素G(4.8×10⁶U)或头孢噻肟(1.0g)进行治疗。仅青霉素组口服1g丙磺舒。各治疗组的感染部位数量如下:青霉素组——尿道37个、直肠9个、宫颈8个、咽部4个;头孢噻肟组——尿道42个、直肠9个、宫颈5个、咽部4个。各治疗组的治愈率均为100%。两组均未观察到不良反应。未发现β-内酰胺酶阳性的淋病奈瑟菌菌株。95%的临床分离株对每毫升小于或等于0.007微克的头孢噻肟和小于或等于0.25微克的青霉素敏感。在本研究中,头孢噻肟在治疗单纯性淋病方面与普鲁卡因青霉素效果相当。